Postoperative Lower Urinary Tract Storage Symptoms: Does Prostate Enucleation Differ from Prostate Vaporization for Treatment of Symptomatic Benign Prostatic Hyperplasia?

被引:15
|
作者
Elkoushy, Mohamed A. [1 ,2 ]
Elshal, Ahmed M. [1 ,3 ]
Elhilali, Mostafa M. [1 ]
机构
[1] McGill Univ, Ctr Hlth, Div Urol, Dept Surg, Montreal, PQ H4A 3J1, Canada
[2] Suez Canal Univ, Dept Urol, Ismailia, Egypt
[3] Mansoura Univ, Urol & Nephrol Ctr, Mansoura, Egypt
关键词
HOLMIUM LASER ENUCLEATION; QUALITY-OF-LIFE; LITHIUM TRIBORATE LASER; PHOTOSELECTIVE VAPORIZATION; TRANSURETHRAL RESECTION; DETRUSOR OVERACTIVITY; METAANALYSIS; ENLARGEMENT; PREDICTORS; PARAMETERS;
D O I
10.1089/end.2015.0202
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To assess the degree of postoperative storage symptoms after GreenLight laser photoselective vaporization of the prostate (PVP) and Holmium laser enucleation of the prostate (HoLEP) for management of benign prostatic hyperplasia (BPH) and its predictors. Methods: A retrospective review was performed for patients who underwent HoLEP or PVP for non catheter-dependent patients with BPH. Patients were followed up at 1, 3, 6, and 12 months and then annually by International Prostate Symptoms Score (IPSS), quality of life index, peak flow rate, residual urine volume, and prostate-specific antigen (PSA) level. Moderate or severe storage symptoms were defined as IPSS storage subscore 9. Results: Of 1673 laser procedures, a total of 1100 procedures met the inclusion criteria including 809 HoLEPs and 291 PVPs. The HoLEP group had significantly larger preoperative prostates and longer operative time. In the HoLEP group, postoperative IPSS was significantly better than in the PVP group at all follow-up points (P<0.05). Storage subscore was significantly higher after PVP and did not improve until 6 months postoperatively when it became comparable with that of the HoLEP group. The number of patients with IPSS-storage score 9 were significantly higher in the PVP group at 1 and 3 months follow-up (37.3% vs 15.1%, P<0.001) and (26.4% vs 17.5%, P=0.004), respectively. XPS-180W was associated with the lowest storage symptoms among the three GreenLight generations at all follow-up visits. In multivariate analysis, baseline IPSS-storage subscore 9, prolonged operative time >100 minutes, and lower percent of postoperative PSA level reduction significantly predicted less improvement of postoperative storage symptoms regardless of the laser procedure. Conclusion: Storage urinary symptoms significantly improved more after HoLEP compared with PVP, irrespective of the generation of GreenLight laser used. Recovery from bothersome storage urinary symptoms after prostate vaporization is time dependent, and baseline degree of storage symptoms, prolonged operative time, and lower percent of postoperative PSA level reduction negatively predicts postoperative improvement of storage symptoms regardless of the laser procedure.
引用
收藏
页码:1159 / 1165
页数:7
相关论文
共 50 条
  • [1] Holmium Laser Enucleation of the Prostate for Persistent Lower Urinary Tract Symptoms After Prior Benign Prostatic Hyperplasia Surgery
    Jaeger, Christopher D.
    Krambeck, Amy E.
    UROLOGY, 2013, 81 (05) : 1025 - 1029
  • [2] Staging of Benign Prostate Hyperplasia is Helpful in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia
    Wang, Delin
    Foo, Keong Tatt
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2010, 39 (10) : 798 - 802
  • [3] Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement
    Ito, Hiroki
    Takanashi, Masato
    Fukazawa, Takeshi
    Takizawa, Hiroki
    Hioki, Mari
    Shinoki, Risa
    Kawahara, Takashi
    Makiyama, Kazuhide
    Kobayashi, Kazuki
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2024, 16 (03)
  • [4] GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine
    Luo, Fei
    Sun, Hong-Hong
    Su, Yan-Hui
    Zhang, Zhi-Hua
    Wang, Ya-Shen
    Zhao, Zhen
    Li, Jian
    LASERS IN MEDICAL SCIENCE, 2017, 32 (04) : 895 - 901
  • [5] Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Jung, Jae Hung
    McCutcheon, Karen Ann
    Borofsky, Michael
    Young, Shamar
    Golzarian, Jafar
    Kim, Myung Ha
    Dahm, Philipp
    Narayan, Vikram M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (03):
  • [6] The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia: The LIFT Study
    Roehrborn, Claus G.
    Gange, Steven N.
    Shore, Neal D.
    Giddens, Jonathan L.
    Bolton, Damien M.
    Cowan, Barrett E.
    Brown, B. Thomas
    McVary, Kevin T.
    Te, Alexis E.
    Gholami, Shahram S.
    Rashid, Prem
    Moseley, William G.
    Chin, Peter T.
    Dowling, William T.
    Freedman, Sheldon J.
    Incze, Peter F.
    Coffield, K. Scott
    Borges, Fernando D.
    Rukstalis, Daniel B.
    JOURNAL OF UROLOGY, 2013, 190 (06) : 2161 - 2167
  • [7] Impact on Sexual Function of Endoscopic Enucleation vs Transurethral Resection of the Prostate for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
    Liu, Yuqing
    Cheng, Yinchu
    Zhuo, Lin
    Liu, Ke
    Xiao, Chunlei
    Zhao, Rongsheng
    Lu, Jian
    Ma, Lulin
    JOURNAL OF ENDOUROLOGY, 2020, 34 (10) : 1064 - 1074
  • [8] The Potential Role of Urinary Microbiome in Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms
    Yu, Seong Hyeon
    Jung, Seung Il
    DIAGNOSTICS, 2022, 12 (08)
  • [9] Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic benign prostatic hyperplasia (&gt;70 ml)
    Mu, Xiao-Nan
    Wang, Si-Jun
    Chen, Ji
    Jin, Xun-Bo
    Huang, Zhong-Xian
    Zhang, Long-Yang
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (05) : 608 - 612
  • [10] Vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    Porst H.
    Sandner P.
    Ulbrich E.
    Current Urology Reports, 2008, 9 (4) : 295 - 301